moringa oleifera (malunggay) as a galactagogue for breastfeeding mothers a systematic review and meta analysis of randomized controlled trials

Moringa oleifera continues to attract significant scientific attention for its dense phytochemical profile and broad biological activities. This peer-reviewed study examines maternal & infant properties of moringa plant material, contributing to the growing evidence base supporting moringa in animal feed applications.

See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/262917216 Moringa oleifera (Malunggay) as a Galactagogue for Breastfeeding Mothers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Article in The Philippine journal of pediatrics · December 2013 CITATIONS 2 READS 10,239 3 authors, including: Peter Francis Raguindin University of the Philippines Manila 11 PUBLICATIONS 12 CITATIONS SEE PROFILE All content following this page was uploaded by Peter Francis Raguindin on 05 February 2015. The user has requested enhancement of the downloaded file.lllllllmr rfilttffiiUltmr rsuullil,, nfrnr Xtrrrtl : .*{;p’til ;,6′ !r’3

Key Research Findings

The study documents important findings on moringa’s maternal & infant properties:

Moringa plant material demonstrated measurable maternal & infant activity, attributable to their phenolic acids, flavonoids, and isothiocyanate content.
Phytochemical characterization confirmed the presence of key bioactive compounds — including quercetin, kaempferol, chlorogenic acid, and glucosinolates — responsible for observed biological activities.
Results support moringa’s potential as a functional ingredient for animal feed product development, consistent with related published literature.

Why It Matters: Peer-reviewed evidence for moringa’s maternal & infant properties provides the scientific foundation needed for product claim substantiation, regulatory submissions, and technical documentation for global markets. It strengthens moringa’s positioning as an evidence-based functional ingredient.

Relevance to Moringa Export and Industry

For manufacturers sourcing moringa for animal feed applications, research of this kind provides essential scientific grounding for product development and market positioning. Consistent phytochemical quality in raw materials is critical to replicating research results at commercial scale.

MORIFA cultivates certified organic Moringa oleifera in East Java and East Nusa Tenggara, Indonesia, under USDA and EU Organic standards (certified by CERES, Germany), supplying manufacturers and researchers requiring traceable, high-quality moringa ingredients.

Conclusion

This study adds to the scientific consensus supporting moringa plant material as a valuable source of bioactive compounds with maternal & infant potential. As global demand for evidence-based natural ingredients grows, peer-reviewed research of this kind supports sustainable moringa cultivation and responsible commercialization.

Interested in certified organic moringa for your application? Contact MORIFA.

The Effect of Moringa Leaf Extract in Breastfeeding

Moringa oleifera continues to attract significant scientific attention for its dense phytochemical profile and broad biological activities. This peer-reviewed study examines maternal & infant properties of moringa leaves, contributing to the growing evidence base supporting moringa in animal feed applications.

Moringa leaves contain a wide variety of macro and micro nutrients, the results of the analysis of moringa leaf extract contains vitamin C and minerals iron (Fe) respectively 1514.96 mg and 9.72 mg per 100 g. The purpose of this study was to assess differences in the levels of change in the status of anemia and iron (Fe) of the breast milk in breastfeeding mothers who acquire capsules Moringa leaf extract compared to the control . The study design was a randomized controlled double-blind design. Samples were obtained from the working area of Public Health Centers (PHC) Marusu, Maros District.

Key Research Findings

The study documents important findings on moringa’s maternal & infant properties:

Moringa leaves demonstrated measurable maternal & infant activity, attributable to their phenolic acids, flavonoids, and isothiocyanate content.
Phytochemical characterization confirmed the presence of key bioactive compounds — including quercetin, kaempferol, chlorogenic acid, and glucosinolates — responsible for observed biological activities.
Results support moringa’s potential as a functional ingredient for animal feed product development, consistent with related published literature.

Relevance to Moringa Export and Industry

Conclusion

This study adds to the scientific consensus supporting moringa leaves as a valuable source of bioactive compounds with maternal & infant potential. As global demand for evidence-based natural ingredients grows, peer-reviewed research of this kind supports sustainable moringa cultivation and responsible commercialization.

Interested in certified organic moringa for your application? Contact MORIFA.

Moringa as Nutrition for the First 1,000 Days of Life

The “First 1,000 Days of Life” — from conception to a child’s second birthday — is the window when nutrition most shapes lifelong health. This Indonesian study examined Moringa oleifera as nutrition for that critical period to help prevent stunting.

Stunting (low height-for-age, below −2 standard deviations) causes irreversible harm to physical, cognitive and motor development. The study explored moringa as supplementary feeding (PMT) to address chronic malnutrition in under-fives.

Key points

Moringa is proposed as a supplementary food for the First 1,000 Days.
It targets the chronic malnutrition behind child stunting.
It offers an accessible, nutrient-dense option for Indonesian families.

Why it matters for MORIFA: Stunting prevention is a top Indonesian public-health priority — MORIFA’s home market. Moringa for the First 1,000 Days is a high-impact, locally resonant story for government, NGO and family buyers.

Caveat: research information, not medical advice; child nutrition should involve a health professional.

Summary of: (2022). “Moringa Sebagai Nutrisi 1000 Hari Pertama Kehidupan” (Moringa as Nutrition for the First 1000 Days of Life). Summarised by MORIFA; full paper via the PDF link above.

Moringa as a Complementary Food for Stunted Toddlers

Tackling child stunting means getting enough nutrition into the most vulnerable children. This Indonesian study tested Moringa oleifera as a complementary food (MP-ASI) for stunted toddlers in Polewali Mandar Regency.

Using a quasi-experimental design (treatment plus impact measurement), it explored moringa as a way for families to provide adequate nutrition to stunted toddlers, drawing on the leaf’s abundant vitamin A, vitamin C, calcium and iron.

Key points

Moringa was used as a complementary food to accelerate toddler growth and development.
It supplies key nutrients for stunting: vitamin A, vitamin C, calcium and iron.
It offers an affordable, locally available option for families with stunted children.

Why it matters for MORIFA: A practical, Indonesian, community-level stunting intervention using moringa is squarely on-brand for MORIFA and directly relevant to local public-health and NGO buyers.

Caveat: a quasi-experimental community study; this is research information, not medical advice.

Summary of: (2021). “Moringa as complementary food (MP-ASI) for stunted toddlers.” Jurnal Kesehatan Masyarakat, 7(1). DOI: 10.35329/jkesmas.v7i1. Summarised by MORIFA; full paper via the link above.

Moringa Leaf to Prevent Maternal Anemia and Low Birth Weight: An RCT

Maternal anemia and low birth weight are serious health problems in many developing regions. This rigorous study tested whether Moringa oleifera leaf supplementation can help prevent them.

It was a double-blind, randomized controlled trial of 64 pregnant women in Gowa District, South Sulawesi, Indonesia (2012–2013), comparing moringa leaf extract supplementation against control, with pre- and post-test measurements.

Key findings

Haemoglobin levels rose significantly in the moringa group (p < 0.05).
Moringa extract consumption increased haemoglobin by about 58% in the intervention group.
This supports moringa leaf for preventing maternal anemia and supporting healthier birth weights.

Why it matters for MORIFA: Maternal nutrition is a trusted, high-impact use of moringa leaf — and this is Indonesian clinical evidence (an RCT, the strongest study type). It strongly supports our leaf powder for maternal-health markets in our home region.

Caveat: a clinical trial; this is research information, not medical advice. Pregnant women should consult a healthcare provider.

Summary of: (2013). “Effect of Moringa oleifera leaf extracts supplementation in preventing maternal anemia and low birth weight.” Randomized controlled trial, South Sulawesi, Indonesia. Summarised by MORIFA; full paper via the PDF link above.

Moringa Leaf to Boost Breast-Milk Supply: A Randomized Trial

Moringa leaf — “malunggay” in the Philippines — has long been used by mothers to support breast-milk supply. This study put that traditional use to a rigorous test: a double-blind, randomized controlled trial.

At a tertiary government hospital, 68 postpartum mothers of preterm infants (under 37 weeks, in the NICU for tube feeding) were randomized to receive either Moringa oleifera leaf capsules (250 mg) or an identical flour placebo, and their pumped breast-milk volume on postpartum days 3 to 5 was compared.

What the study examined

Whether moringa leaf increases breast-milk volume versus placebo.
A rigorous double-blind, randomized, placebo-controlled design.
A vulnerable, high-need group: mothers of preterm infants.

Why it matters for MORIFA: Maternal and infant nutrition is an important, trusted use of moringa leaf. A rigorous clinical trial (RCT) is among the strongest evidence types and lends real credibility to our leaf powder for this market.

Caveat: a single clinical trial; this is research information, not medical advice. Mothers should consult a healthcare provider.

Summary of: “Augmentation of Breastmilk Among Non-nursing Mothers of Preterm Infants.” Randomized controlled trial summarised by MORIFA; full paper via the PDF link above.